# ![@tradingsssss Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1636301249992876033.png) @tradingsssss tradingbiotech

tradingbiotech posts on X about $crvs, $nktr, $nvct, $abvx the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::1636301249992876033/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1636301249992876033/c:line/m:interactions.svg)

- [--] Week [------] +82%
- [--] Month [-------] +167%
- [--] Months [---------] +531%
- [--] Year [---------] +302%

### Mentions: [--] [#](/creator/twitter::1636301249992876033/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1636301249992876033/c:line/m:posts_active.svg)

- [--] Week [--] +24%
- [--] Month [---] +43%
- [--] Months [-----] +168%
- [--] Year [-----] +52%

### Followers: [-----] [#](/creator/twitter::1636301249992876033/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1636301249992876033/c:line/m:followers.svg)

- [--] Week [-----] +1.90%
- [--] Month [-----] +11%
- [--] Months [-----] +87%
- [--] Year [-----] +146%

### CreatorRank: [-------] [#](/creator/twitter::1636301249992876033/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1636301249992876033/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  49.23% [finance](/list/finance)  6.92% [cryptocurrencies](/list/cryptocurrencies)  1.54% [countries](/list/countries)  0.77%

**Social topic influence**
[$crvs](/topic/$crvs) #3, [$nktr](/topic/$nktr) #5, [$nvct](/topic/$nvct) #9, [$abvx](/topic/$abvx) #7, [$kymr](/topic/$kymr) #2, [trend](/topic/trend) 5.38%, [in the](/topic/in-the) 4.62%, [this is](/topic/this-is) 3.85%, [$cccc](/topic/$cccc) 3.85%, [$dawn](/topic/$dawn) 3.85%

**Top accounts mentioned or mentioned by**
[@hothomaswphelps](/creator/undefined) [@somecuriousgirl](/creator/undefined) [@financebully](/creator/undefined) [@semodough](/creator/undefined) [@liteupthedark1](/creator/undefined) [@joserestonva](/creator/undefined) [@jfais20](/creator/undefined) [@seedy19tron](/creator/undefined) [@chiragkh](/creator/undefined) [@jd4for4](/creator/undefined) [@amaymd](/creator/undefined) [@soowannaway](/creator/undefined) [@fredwmeyer666](/creator/undefined) [@automaticnba](/creator/undefined) [@realguenel](/creator/undefined) [@biovalues](/creator/undefined) [@joecool20250204](/creator/undefined) [@doepkemichel](/creator/undefined) [@bananaoncology](/creator/undefined) [@eggcapitalws](/creator/undefined)

**Top assets mentioned**
[Nuvectis Pharma, Inc.  (NVCT)](/topic/$nvct) [Abivax SA (ABVX)](/topic/$abvx) [Kymera Therapeutics, Inc. (KYMR)](/topic/$kymr) [C4 Therapeutics, Inc (CCCC)](/topic/$cccc) [Day One Biopharmaceuticals, Inc. (DAWN)](/topic/$dawn) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Apogee Therapeutics, Inc. (APGE)](/topic/$apge) [Evommune, Inc. (EVMN)](/topic/$evmn) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Oruka Therapeutics, Inc. Common Stock (ORKA)](/topic/$orka) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Eli Lilly and Company (LLY)](/topic/$lly) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Ocular Therapeutix, Inc. (OCUL)](/topic/$ocul) [Alibaba Group (BABA)](/topic/$baba) [Coconut Chicken (CCC)](/topic/$ccc) [Caribou Biosciences, Inc. (CRBU)](/topic/$crbu) [Inhibikase Therapeutics, Inc. (IKT)](/topic/$ikt) [Tarsus Pharmaceuticals, Inc. (TARS)](/topic/$tars) [Structure Therapeutics Inc. (GPCR)](/topic/$gpcr) [Prime Medicine, Inc. (PRME)](/topic/$prme) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Royalty Pharma plc (RPRX)](/topic/$rprx) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [AbCellera Biologics Inc. (ABCL)](/topic/$abcl) [Amgen, Inc. (AMGN)](/topic/$amgn) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Synthetify (SNY)](/topic/$sny) [Legend Biotech Corp (LEGN)](/topic/$legn) [Revolution Medicines, Inc. (RVMD)](/topic/$rvmd) [PepGen Inc. (PEPG)](/topic/$pepg) [ArriVent BioPharma, Inc.  (AVBP)](/topic/$avbp) [BEAM (BEAM)](/topic/$beam)
### Top Social Posts
Top posts by engagements in the last [--] hours

"$NKTR $CRVS $APGE $KYMR $EVMN why are we even trying to compete with one another 😂 $NKTR $CRVS https://t.co/cJhhh1lPTx $NKTR $CRVS https://t.co/cJhhh1lPTx"  
[X Link](https://x.com/tradingsssss/status/2022955344960672033)  2026-02-15T08:45Z [----] followers, [----] engagements


"$NVCT above this area and holding"  
[X Link](https://x.com/tradingsssss/status/2013058056045973659)  2026-01-19T01:16Z [----] followers, [---] engagements


"$NVCT we're above this area as well"  
[X Link](https://x.com/tradingsssss/status/2014161735729717652)  2026-01-22T02:22Z [----] followers, [---] engagements


"$NVCT next one up here"  
[X Link](https://x.com/tradingsssss/status/2014509210999128282)  2026-01-23T01:23Z [----] followers, [---] engagements


"$NVCT well this looks really good added more yesterday at the open"  
[X Link](https://x.com/tradingsssss/status/2016324621017199018)  2026-01-28T01:37Z [----] followers, [---] engagements


"$NVCT 👀👀👀"  
[X Link](https://x.com/tradingsssss/status/2020877071413879054)  2026-02-09T15:06Z [----] followers, [---] engagements


"$NVCT above this area now"  
[X Link](https://x.com/tradingsssss/status/2021022774069006526)  2026-02-10T00:45Z [----] followers, [---] engagements


"$NVCT Retesting here"  
[X Link](https://x.com/tradingsssss/status/2021241589427736991)  2026-02-10T15:15Z [----] followers, [---] engagements


"@BioValues $NVCT is a spec play with enormous upside potential that's not one of the [--] biotechs"  
[X Link](https://x.com/tradingsssss/status/2021962636536197184)  2026-02-12T15:00Z [----] followers, [---] engagements


"i dont even think $KYMR will be a close competitor to $CRVS: - STAT6 knockout and degradation skews the inflammation towards a Th17 disease which is why they excluded pts with psoriasis in their trials. If they get any mixed Th2/Th17 patients you might not see efficacy in those pts = efficacy capped - STAT6 degradation cannot hit other non-STAT6 Th2 inflammation pathways = efficacy capped - Phase 1b filtered out dupi and JAK failures and only allowed prior dupi pts that were known responders (22% of their pt population) so no conclusions can be made here - STAT6 is widely expressed in the"  
[X Link](https://x.com/tradingsssss/status/2022523244121854295)  2026-02-14T04:08Z [----] followers, [---] engagements


"$NKTR $CRVS $NKTR $CRVS don't understand the animosity between the two names both work on tregs and $NKTR's data provides a nice read through to $CRVS drug and vice versa most BPs talk about this and this is being talked about the same way with $ABVX and obefazimod in IBD but a safe $NKTR $CRVS don't understand the animosity between the two names both work on tregs and $NKTR's data provides a nice read through to $CRVS drug and vice versa most BPs talk about this and this is being talked about the same way with $ABVX and obefazimod in IBD but a safe"  
[X Link](https://x.com/tradingsssss/status/2022831506956198307)  2026-02-15T00:33Z [----] followers, [----] engagements


"I agree there will be multiple BICs in each differentiator in this heterogeneous disease and we've laid most of these differentiations. One that's probably not talked about is the indeterminate CTCL/AD presentation CTCL treated with dupixent actually makes it worse so there's this diagnosis risk for doctors and patients and there's an option for $CRVS here as they've shown to work on both (it's probably its strongest 1L argument) I guess you could define a BIC or even a Best in Disease based on how many differentiators can they be BIC in. Just having many differentiators is probably not"  
[X Link](https://x.com/tradingsssss/status/2023152915754717253)  2026-02-15T21:50Z [----] followers, [---] engagements


"$NTLA i dont think is done but probably close to done its still missing the liquidation candle that wipes out everyone to get this all started 300$ range from range low to range high and if it gets above it it's a 4-5x from here"  
[X Link](https://x.com/tradingsssss/status/1872978868883374261)  2024-12-28T12:12Z [----] followers, [---] engagements


"$NTLA this is crazy tbh"  
[X Link](https://x.com/tradingsssss/status/1880159985117851679)  2025-01-17T07:47Z [----] followers, [----] engagements


"$SRPT needs to get above this trend"  
[X Link](https://x.com/tradingsssss/status/1964968316344426937)  2025-09-08T08:25Z [----] followers, [----] engagements


"$ABVX faked out usually a good sign for when it gets back up"  
[X Link](https://x.com/anyuser/status/1973563672325923138)  2025-10-02T01:40Z [----] followers, [----] engagements


"$CCC retesting trend after the failed breakout"  
[X Link](https://x.com/tradingsssss/status/1995674939295498393)  2025-12-02T02:02Z [----] followers, [---] engagements


"$CRBU rejected the trend flip"  
[X Link](https://x.com/tradingsssss/status/1995675679254532504)  2025-12-02T02:05Z [----] followers, [----] engagements


"$CCCC retesting trend"  
[X Link](https://x.com/tradingsssss/status/1998610846784827554)  2025-12-10T04:28Z [----] followers, [---] engagements


"if you like $ABVX bc it's oral unique MOA and in a huge disease market you might like $CRVS which is also an oral unique MOA which targets Th2 and Th17 diseases so that's all of Dupi's indications + Bimzelx's indications or Rinvoq w/o the black box Oh yeah there's also a phase [--] PTCL that doesn't have a SOC that works and phase [--] showed [----] months median OS compared to SOC which is usually 6-12 months And also an ALPS indication where it could get immediate approval from this FDA after their proof of concept study Oh yeah it could work in combination with immunotherapies in solid tumours."  
[X Link](https://x.com/tradingsssss/status/1998709620651770297)  2025-12-10T11:01Z [----] followers, 10.9K engagements


"here's an example of meh dec trading: $CCCC though this would be great but closed below previous breakout area no significant losses but had some capital tied up and was able to cut close to breakeven prices but could've been in other names instead of this"  
[X Link](https://x.com/tradingsssss/status/2000718913559249339)  2025-12-16T00:05Z [----] followers, [---] engagements


"$CCCC Lost trend here"  
[X Link](https://x.com/tradingsssss/status/2001098148715131084)  2025-12-17T01:12Z [----] followers, [---] engagements


"$IKT looks nice here a lot of cardiovascular drugs are significantly undervalued $TECX is at a 140m EV this is somewhere there"  
[X Link](https://x.com/tradingsssss/status/2003968773016244674)  2025-12-24T23:19Z [----] followers, [----] engagements


"@seedy19tron just hoping for some $KYMR type of love 😘"  
[X Link](https://x.com/tradingsssss/status/2012312233859256806)  2026-01-16T23:53Z [----] followers, [---] engagements


"$CRVS should be why any efficacy comparisons to any other programs is hard to use bc pt populations here are different. There's very limited data (I think Ebglyss has some on dupi-exp pts but i think they werent failures and $APGE will have jak-failed pts) if it beats JAK and/or dupi efficacies in this pt pop then this might get very interesting. I think there's a BP already ready to give it a swing if the data beats or is close to dupi in dupi and JAK failures We are in a bull market after all where early stage companies are rewarded for promising data maybe in a bear it might be flat or"  
[X Link](https://x.com/tradingsssss/status/2012589739321487822)  2026-01-17T18:16Z [----] followers, [----] engagements


"$TARS Good short from the 80s when it broke down range i didnt take it of course"  
[X Link](https://x.com/tradingsssss/status/2013059048271135128)  2026-01-19T01:20Z [----] followers, [---] engagements


"$DAWN underrated move here have some position here small - 85% tied into $CRVS and $ABVX"  
[X Link](https://x.com/tradingsssss/status/2013742589628031193)  2026-01-20T22:37Z [----] followers, [----] engagements


"@chiragkh fingers crossed on the $ABVX buyout $NVCT on paper looks promising but im sure there's a reason its at 200m EV just haven't had the time to look at it"  
[X Link](https://x.com/tradingsssss/status/2013924631170654413)  2026-01-21T10:40Z [----] followers, [----] engagements


"$KURA v cheap but the chart is not so fun"  
[X Link](https://x.com/tradingsssss/status/2014162340963606614)  2026-01-22T02:24Z [----] followers, [---] engagements


"$CCCC not so good"  
[X Link](https://x.com/tradingsssss/status/2014162423838568674)  2026-01-22T02:25Z [----] followers, [---] engagements


"$BHVN its above this area on heck of a pipeline but do they even have cash"  
[X Link](https://x.com/tradingsssss/status/2014163049670922464)  2026-01-22T02:27Z [----] followers, [---] engagements


"$GPCR Is ripping and filled that wick been a solid run since 18-20s"  
[X Link](https://x.com/tradingsssss/status/2014163241300308094)  2026-01-22T02:28Z [----] followers, [---] engagements


"$PRME solid move from the trend reclaim"  
[X Link](https://x.com/tradingsssss/status/2014509565409427706)  2026-01-23T01:24Z [----] followers, [---] engagements


"$DAWN dont like these wicks still looks good but dont like it in the short term"  
[X Link](https://x.com/tradingsssss/status/2014864552572420254)  2026-01-24T00:55Z [----] followers, [---] engagements


"$NVCT looking good here"  
[X Link](https://x.com/tradingsssss/status/2014864624253055345)  2026-01-24T00:55Z [----] followers, [---] engagements


"@joecool20250204 @doepke_michel $PTGX should just transform themselves to $RPRX with their own r&d pipeline"  
[X Link](https://x.com/tradingsssss/status/2015787881227485307)  2026-01-26T14:04Z [----] followers, [---] engagements


"$DAWN those wicks dont matter we're just going to keep grinding up trend is up"  
[X Link](https://x.com/tradingsssss/status/2016324539983265804)  2026-01-28T01:36Z [----] followers, [---] engagements


"$AGIO above trend here too"  
[X Link](https://x.com/tradingsssss/status/2016324902023004384)  2026-01-28T01:38Z [----] followers, [---] engagements


"$ABVX I don't want to be that guy but What does this look like to you 👀"  
[X Link](https://x.com/tradingsssss/status/2016828042178592880)  2026-01-29T10:57Z [----] followers, [----] engagements


"wow literally went from 4B per year as a 2L post-dupi drug to a zero meanwhile $ABCL couldnt get its ox40 off the ground Another OX40 update and it's not good. On an analyst call Sunday Kyowa Kirin disclosed a case of Karposi's sarcoma with rocatinlimab in a "high risk" patient according to a Jefferies note. Recall last week $AMGN returned roca to Kyowa. Another OX40 update and it's not good. On an analyst call Sunday Kyowa Kirin disclosed a case of Karposi's sarcoma with rocatinlimab in a "high risk" patient according to a Jefferies note. Recall last week $AMGN returned roca to Kyowa"  
[X Link](https://x.com/tradingsssss/status/2018307871088554040)  2026-02-02T12:57Z [----] followers, [----] engagements


"$CRVS will have [--] phase [--] ready indications by 2027/28 with HS Asthma and AtD and potentially PTCL approval All potentially best in class and best in disease in PTCL HS and AtD which are the two biggest skin markets that a safe and oral option will help grow Both will have earlier usage in the moderate population that is 2-3x bigger than the current biologic TAM due to safety and convenience Now try to price it with that context https://twitter.com/i/web/status/2018696730813079909 https://twitter.com/i/web/status/2018696730813079909"  
[X Link](https://x.com/tradingsssss/status/2018696730813079909)  2026-02-03T14:43Z [----] followers, [---] engagements


"$CRVS holding trend here waiting for a catalyst i wonder what could be next"  
[X Link](https://x.com/tradingsssss/status/2018867717307298300)  2026-02-04T02:02Z [----] followers, [----] engagements


"$NVCT this has such low float that any positive catalyst will rocket this trend flips on the weekly"  
[X Link](https://x.com/tradingsssss/status/2018868840818774466)  2026-02-04T02:06Z [----] followers, [---] engagements


"Imagine a drug that could work on both I'd imagine that drug will be prescribed 1L in AD just because it could reduce diagnosis risk #Dupilumab is uncovering hidden skin lymphomas why some patients do not respond to Dupi as they do not have AD. - CTCL and atopic dermatitis/eczema can present similarly and misdiagnosis may be high https://t.co/KuU8pRy2DE https://t.co/kRxySpBjWt #Dupilumab is uncovering hidden skin lymphomas why some patients do not respond to Dupi as they do not have AD. - CTCL and atopic dermatitis/eczema can present similarly and misdiagnosis may be high"  
[X Link](https://x.com/tradingsssss/status/2018912522183807024)  2026-02-04T05:00Z [----] followers, [---] engagements


"$PALI rough break down looking likely here does $PALI go down on bad $ABVX maintenance data"  
[X Link](https://x.com/tradingsssss/status/2019230458257736091)  2026-02-05T02:03Z [----] followers, [----] engagements


"@Banana_Oncology @EggCapitalWS Puts a lot of pressure on the maintenance data to raise off a stock pop Companies like $CRVS will go from being 1.5-2 years behind to one year behind and their CMC work will be easier and less complicated so less chances of a CRL"  
[X Link](https://x.com/tradingsssss/status/2019597057452044536)  2026-02-06T02:20Z [----] followers, [---] engagements


"@AlexandrG1980 @chaotropy btw $KYMR has not had a drug exit phase [--] and has dropped more programs than they have open"  
[X Link](https://x.com/tradingsssss/status/2020054536703111538)  2026-02-07T08:38Z [----] followers, [---] engagements


"$KYMR their phase 2b trial is really dependent on how much they can filter out the mixed Th2/Th17 AD patients from the Th2 dominant diseases Can they do this in their phase [--] trial Yes - they filtered for patients that prior dupi responses but could not continue treatment bc of non safety and efficacy reasons Can they do this in a phase 2b or phase [--] trial I doubt they can filter this out 🚨 New paper: Persistent activation of #STAT6 neutrophilic recruitment in chronic atopic dermatitis Insight to $KYMR KT-621 efficacy in AD Where KT-621 likely highly effective #Dupilumab: - keratinocyte"  
[X Link](https://x.com/tradingsssss/status/2020756471345205448)  2026-02-09T07:07Z [----] followers, [---] engagements


"$KYMR also KT-621 might make these mixed Th2/17 pts worse dropping those EASI scores if theyre in the treatment arm https://x.com/i/status/1979085598087385321 Hypothesis: STAT6 degrader IL-4R antibody $KYMR New Ph2b atopic dermatitis exclusion is #Th17 specific suggests predicted pathway limitation of downstream #STAT6 may Th17 skin disease via IL-6/STAT3 and common Q576R polymorphism Ph1b 4Q25 may tell $REGN $SNY #Dupilumab https://t.co/WE8KJkbqP9 https://x.com/i/status/1979085598087385321 Hypothesis: STAT6 degrader IL-4R antibody $KYMR New Ph2b atopic dermatitis exclusion is #Th17 specific"  
[X Link](https://x.com/tradingsssss/status/2020821169427915012)  2026-02-09T11:24Z [----] followers, [---] engagements


"@financebully @InteriusBio $LEGN is cheap here"  
[X Link](https://x.com/tradingsssss/status/2020835283135340950)  2026-02-09T12:20Z [----] followers, [---] engagements


"$ABVX range high next"  
[X Link](https://x.com/tradingsssss/status/2021022999479247072)  2026-02-10T00:46Z [----] followers, [----] engagements


"$CRVS nothing till it flips 22"  
[X Link](https://x.com/tradingsssss/status/2021023184519299218)  2026-02-10T00:47Z [----] followers, [---] engagements


"$DAWN looking good here reclaimed trend and consolidated above it"  
[X Link](https://x.com/tradingsssss/status/2021023472785523196)  2026-02-10T00:48Z [----] followers, [---] engagements


"$ZURA tried to break above but couldn't hold"  
[X Link](https://x.com/tradingsssss/status/2021025741119643796)  2026-02-10T00:57Z [----] followers, [---] engagements


"$RVMD just hovering below trend"  
[X Link](https://x.com/tradingsssss/status/2021025982522720485)  2026-02-10T00:58Z [----] followers, [---] engagements


"$NKTR will 12% be enough to raise cash for their phase 3s heard they need 500m for the phase 3s with 30-40m cash burn dont think there will be a settlement anytime soon $NKTR surprised its not up even more after the slides were released $NKTR surprised its not up even more after the slides were released"  
[X Link](https://x.com/tradingsssss/status/2021215774145147351)  2026-02-10T13:32Z [----] followers, [----] engagements


"@somecuriousgirl suing your BP partner is not a good reputation to have across other BP partners if BO i think $LLY will be the ones that buyout to remove the lawsuit"  
[X Link](https://x.com/tradingsssss/status/2021220806026539370)  2026-02-10T13:52Z [----] followers, [---] engagements


"@somecuriousgirl let's see - pharma is all about relationships and everyone knows each other. i wouldn't be so quick to rule that out i dont think any BP will want to take that risk and sue $LLY"  
[X Link](https://x.com/tradingsssss/status/2021226245661265996)  2026-02-10T14:14Z [----] followers, [--] engagements


"$ABVX looking good here"  
[X Link](https://x.com/tradingsssss/status/2021236966587523291)  2026-02-10T14:57Z [----] followers, [----] engagements


"$EVMN retesting previous ATHs here"  
[X Link](https://x.com/tradingsssss/status/2021243310682104164)  2026-02-10T15:22Z [----] followers, [---] engagements


"$NKTR coming up to this area now let's see how it trades after offering"  
[X Link](https://x.com/tradingsssss/status/2021244037798207952)  2026-02-10T15:25Z [----] followers, [---] engagements


"@LabbRadar It has a bigger TAM than $NKTR 🫡"  
[X Link](https://x.com/tradingsssss/status/2021251109801562477)  2026-02-10T15:53Z [----] followers, [---] engagements


"$CRVS imagine a catalyst coming out of nowhere 👀 $CRVS short interest intriguing that at any time with Richard Miller & Wifes connections could land partner at anytime for First in class Oral - potentially modifying https://t.co/sYddo9dQVx $CRVS short interest intriguing that at any time with Richard Miller & Wifes connections could land partner at anytime for First in class Oral - potentially modifying https://t.co/sYddo9dQVx"  
[X Link](https://x.com/tradingsssss/status/2021377857717666133)  2026-02-11T00:16Z [----] followers, [----] engagements


"$NKTR anyone know whether prior JAK and biologic experienced pts will be included in their phase [--] trials"  
[X Link](https://x.com/tradingsssss/status/2021557349044068773)  2026-02-11T12:10Z [----] followers, [----] engagements


"@semodough All of this fits soquelitinib's profile $CRVS"  
[X Link](https://x.com/tradingsssss/status/2021595714703249422)  2026-02-11T14:42Z [----] followers, [---] engagements


"@liteupthedark1 I don't trade a drug that could potentially be dupi-bimzelx in a pill or Rinvoq without a BBW 👀 This could be 30-40B peak sales if it all works"  
[X Link](https://x.com/tradingsssss/status/2021726638858547231)  2026-02-11T23:22Z [----] followers, [---] engagements


"$NVCT looks really good to me"  
[X Link](https://x.com/tradingsssss/status/2021806284170015047)  2026-02-12T04:39Z [----] followers, [---] engagements


"$NKTR consolidates at 56-60s then we go again"  
[X Link](https://x.com/tradingsssss/status/2021806897473753426)  2026-02-12T04:41Z [----] followers, [----] engagements


"@JD4for4 @semodough you concerned about the osi GI AEs compounding the NXP-900 GI AEs think lorlatinib AEs should be quite good"  
[X Link](https://x.com/tradingsssss/status/2021807793419039118)  2026-02-12T04:45Z [----] followers, [--] engagements


"@byebyegoodguy @A_May_MD its how you know you are in a bull market weve seen it for a couple of companies offerings get punished in a bear market"  
[X Link](https://x.com/tradingsssss/status/2021962395506397453)  2026-02-12T14:59Z [----] followers, [--] engagements


"$CRVS Tregs are pretty integral in that durative effect You can see it in the $NKTR and $CRVS data The difference is the speed of the responses: $CRVS is reaching $NKTR W16 response at W4 & [--] (don't kill me I know it's a small sample size but $CRVS is also doing this in a population that includes 40-50% dupi and JAK failures not a fully naive pt pop so gotta give credit to that) Which makes sense MOA wise #Rezpeg is only affecting the Treg side of the treg/teff equation so to get it to balance you have to dose more and for a longer period (That's why they're extending the induction period"  
[X Link](https://x.com/tradingsssss/status/2022207909497888886)  2026-02-13T07:15Z [----] followers, [--] engagements


"$PEPG pitch perfect trading right here and im not in it 🤣"  
[X Link](https://x.com/tradingsssss/status/2022309398266478690)  2026-02-13T13:58Z [----] followers, [---] engagements


"@JoseRestonVA Understand 🫡 Just saw you added a couple of AD names with $KYMR $APGE $CRVS $EVMN"  
[X Link](https://x.com/tradingsssss/status/2022487921216069890)  2026-02-14T01:47Z [----] followers, [---] engagements


"no requirements of food intake and having it with food is better for compliance anyways currently BID and being tested for QD (likely to work since 400mg QD can induce up to 90% kinase inhibition and covalent binding can keep that for longer) dose doesn't need to be refined as correlation with dose and kinase inhibition has been established https://twitter.com/i/web/status/2022533589028757683 https://twitter.com/i/web/status/2022533589028757683"  
[X Link](https://x.com/tradingsssss/status/2022533589028757683)  2026-02-14T04:49Z [----] followers, [--] engagements


"$AVBP dont know what they do roughly around 600m EV above trend and approaching this resistance area @tradingsssss Look at $AVBP fren @tradingsssss Look at $AVBP fren"  
[X Link](https://x.com/tradingsssss/status/2014260833451381149)  2026-01-22T08:56Z [----] followers, [---] engagements


"@jfais20 their next gen ITK still hit RLK/TXK which when spared keeps Th1 for cancer and viral surveillance and induces Treg differentiation if $ACRS still hits RLK/TXK then I think it might be another JAK https://x.com/tradingsssss/status/2016339702593552645s=20 @BlueWinterMgmt they overlap so hard to know exactly I think this probably speaks to how difficult it is to create an ITK-selective. $ACRS have addressed this as well. $ACRS has been trying to create an ITK selective inhibitor and this is one of their first attempts at it Their 2nd 3rd and https://t.co/nwqnc8Rtny"  
[X Link](https://x.com/tradingsssss/status/2021758581226582430)  2026-02-12T01:29Z [----] followers, [---] engagements


"btw commercial window is an issue at present but it's easily mitigated: - patent extensions will probably push this to [----] - if durative effect keeps up then there will be a very strong MOU patent on the dosing and durative effect - patent on Th1 sparing Treg induction etc - if safety holds up lots of combination tx possibilities with Anti-TNF and Anti-Fibrotic medications - there's lots of manufacturing formulation for extended release patents that you can pull up - patents on new indications that it can be used (Tfh = B-cell/T-cell mixed diseases Th2 and/or Th17 diseases) - there's also a"  
[X Link](https://x.com/tradingsssss/status/2022528291513737411)  2026-02-14T04:28Z [----] followers, [---] engagements


"Likewise Nemluvio is probably a combination of differentiation and lack of options in AD and Amlitelimab's commercial launch could give us an idea on how desperate doctors still are I can only speculate on why they moved on from KT-474 since they did cancelled the program just before readout of their phase [--] HS and AD studies - maybe an efficacy issue I agree tho both $KYMR and $CRVS are still early have a lot of to prove in phase 2b and all the best on the pair trade One thing I can't fault $KYMR is how they've been able to play the capital markets and raise all this cash despite having 6"  
[X Link](https://x.com/tradingsssss/status/2022660992736411759)  2026-02-14T13:15Z [----] followers, [---] engagements


"Even in Psoriasis there's multiple drugs within the established MOAs so definitely lots of room here - IL17 A/F: Bimzelx Sonelukimab Consentx (IL17A only) Taltz (IL17A only) - IL 23: Tremfya Skyrizi Imluya Omvoh - JAK: Rinvoq - TYK2: Sotyktu Envudeucitinib Zaso - TNF: Humira Enbrel Remicade - PDE4: Otezla https://twitter.com/i/web/status/2022663205705715840 https://twitter.com/i/web/status/2022663205705715840"  
[X Link](https://x.com/tradingsssss/status/2022663205705715840)  2026-02-14T13:24Z [----] followers, [---] engagements


"My literal feed rn is $ABVX holders promising to name their kids colitis Marc Obe And @HOThomasWPhelps posting some $CRVS alpha $CRVS Biggest concern I hear is safety of Cohort [--] w/ longer drug exposure. #Soquelitinib low dose Cohort 1/2 had EASI-75 of 29% (n=24) matching #dupilumab and higher dose Cohort [--] had EASI-75 reduction of 50% matching JAKi #upadacitinib So I see [--] possibilities regarding https://t.co/p8Xd4bPFF9 $CRVS Biggest concern I hear is safety of Cohort [--] w/ longer drug exposure. #Soquelitinib low dose Cohort 1/2 had EASI-75 of 29% (n=24) matching #dupilumab and higher dose"  
[X Link](https://x.com/tradingsssss/status/1998705489262293111)  2025-12-10T10:44Z [----] followers, 14.7K engagements


"$NVCT playing these breakouts have been choppy recently but like the program and probably worth to follow the trend here tho my money is mostly made in that consolidation period at the bottom and playing the trend flip my TA strategy generally struggles when markets have moved https://twitter.com/i/web/status/2011482732728049825 https://twitter.com/i/web/status/2011482732728049825"  
[X Link](https://x.com/tradingsssss/status/2011482732728049825)  2026-01-14T16:57Z [----] followers, [---] engagements


"I'm in $ABVX and have a small position in $DAWN I'm intrigued by $NVCT with their Src inhibitor - kind of a similar playbook to Soquelitinib - targeting an upstream confirmation of Src before oncogenic signal - shown some really nice pre-clinical work to prove their MOA works and their rationale for potential durability - Highly selective Src inhibitor - lowering toxicities that Dasatinib had - could potential break ALK and EGFR resistance based on their pre-clinical data (all pts with these mutations become resistant after one year) - working on a pt pop that does not have many options."  
[X Link](https://x.com/anyuser/status/2013922539958083664)  2026-01-21T10:32Z [----] followers, [----] engagements


"$CRVS Tregs are pretty integral in inducing that durative effect You can see it in the $NKTR and $CRVS data The difference is the speed of the responses: $CRVS is reaching $NKTR W16 response at W4 & [--] (don't kill me I know it's a small sample size but $CRVS is also doing this in a population that includes 40-50% dupi and JAK failures not a fully naive pt pop so gotta give credit to that) Which makes sense MOA wise #Rezpeg is only affecting the Treg side of the treg/teff equation so to get it to balance you have to dose more and for a longer period (That's why they're extending the induction"  
[X Link](https://x.com/tradingsssss/status/2022208473891844409)  2026-02-13T07:17Z [----] followers, 10.5K engagements


"$NKTR $CRVS don't understand the animosity between the two names both work on tregs and $NKTR's data provides a nice read through to $CRVS drug and vice versa most BPs talk about this and this is being talked about the same way with $ABVX and obefazimod in IBD but a safe oral drug increases specialty drug use further into the moderate AD population. This then increases the TAM for everybody else. It's literally the tide that lifts all boats If you're in the AD space I don't think you'd want to shoot down the potential of an safe and effective oral drug entering the market 🫡 $CRVS Tregs are"  
[X Link](https://x.com/tradingsssss/status/2022329612005744648)  2026-02-13T15:18Z [----] followers, [----] engagements


"It's a smart bet I have a slightly different perspective on it: Dupi's [----] LOE will be unique in a way where they will still be a Best in Disease gold standard product. When dupi biosimilars come into the market they will be widely used bc of this gold standard efficacy and safety combined with the discounted price (40-70% discount) This creates a dynamic where payers will need to evaluate whether the premium they're paying for your drug is more value than a dupi biosimilar. This also increases the amount of dupi failures and dupi experienced AD in the market So the question every drug"  
[X Link](https://x.com/tradingsssss/status/2022601827238412618)  2026-02-14T09:20Z [----] followers, [----] engagements


"@JoseRestonVA also depends on which differentiators you have lots of different combinations that you can have but I think the main focal point that were both harping on is that THERE'S ROOM FOR MANY WINNERS 🫡"  
[X Link](https://x.com/tradingsssss/status/2023173229679124719)  2026-02-15T23:11Z [----] followers, [--] engagements


"$BHVN solid here"  
[X Link](https://x.com/tradingsssss/status/2014509644690186332)  2026-01-23T01:25Z [----] followers, [---] engagements


"@DJMatthews80 @AndrewKSchlecht No chance"  
[X Link](https://x.com/tradingsssss/status/1720682274650513666)  2023-11-04T05:59Z [----] followers, [---] engagements


"@PrincrOfAlex @mldiffley @affewrld modern fuel hit different tho"  
[X Link](https://x.com/tradingsssss/status/1725855835681857946)  2023-11-18T12:37Z [----] followers, [----] engagements


"@CurrySandwiches Steph cooking is the counter to this drop defense Game [--] and [--] showed you that Game [--] was they tried to stop Steph and it backfired Game [--] they had no more answers Couldnt contain Steph couldnt contain the warriors offense"  
[X Link](https://x.com/tradingsssss/status/1728750616170864835)  2023-11-26T12:20Z [----] followers, [----] engagements


"@GeneInvesting @ClutchPoints You can lift your pivot foot you just cant land with your pivot foot with the ball"  
[X Link](https://x.com/tradingsssss/status/1731959190321864779)  2023-12-05T08:50Z [----] followers, [---] engagements


"@hmmmmkay first it was dame then it was trae then it was luka then now its hali it never ends until their heliocentric style of play and production results in chips theyre nothing more than just pretenders"  
[X Link](https://x.com/tradingsssss/status/1732067692750966994)  2023-12-05T16:01Z [----] followers, [----] engagements


"@KevonLooneyMuse youd lose the minutes against the teams starters youd lose the minutes against the bench bc starters are just that bad down by [--] at half HAHAHHA"  
[X Link](https://x.com/tradingsssss/status/1734873064616481076)  2023-12-13T09:49Z [----] followers, [----] engagements


"🧵 Threading Through My Trades Part [--] $BEAM: Been tracking this since August [----] and mapped out the chart I liked $BEAM bc of their base editing program cash on hand and I was able to execute the chart as it bottomed perfectly Let's take a look on the journey"  
[X Link](https://x.com/tradingsssss/status/1735221600096776643)  2023-12-14T08:54Z [----] followers, 10.4K engagements


"@LoneyLow @LarryDavidbkup @famouslos32 😂😂😂 he generally gets grabbed prior to getting to those 3s and then gets slapped and hit on the layups he takes a lot of no calls there"  
[X Link](https://x.com/tradingsssss/status/1739489031917093276)  2023-12-26T03:31Z [----] followers, [---] engagements


"@FredWMeyer666 For a Nadal fan he actually posts more about Djokovic 😂"  
[X Link](https://x.com/tradingsssss/status/1741390205129769188)  2023-12-31T09:25Z [----] followers, [---] engagements


"@FredWMeyer666 should change your profile picture to Novak bc you talk about Novak more than Rafa 😂😂😂"  
[X Link](https://x.com/tradingsssss/status/1747080030742814799)  2024-01-16T02:15Z [----] followers, [---] engagements


"@nonbiascurryfan @30Burner_ @WarriorsMuse Post all star break Steph is a different human"  
[X Link](https://x.com/tradingsssss/status/1756198989425512782)  2024-02-10T06:10Z [----] followers, [---] engagements


"$NTLA took a position here Finally breaking out of this local high Hoping to see $32"  
[X Link](https://x.com/tradingsssss/status/1813749202033496095)  2024-07-18T01:34Z [----] followers, [----] engagements


"@bio_2024 seems like a decent breakout $VYTX"  
[X Link](https://x.com/tradingsssss/status/1838963106132926536)  2024-09-25T15:25Z [----] followers, [---] engagements


"@kparks510 @byisaacg lol this guy dont know ball putting Wiggs in any trades"  
[X Link](https://x.com/tradingsssss/status/1854435980981465388)  2024-11-07T08:09Z [----] followers, [----] engagements


"@PoetofGallifrey @DameDeadAF @jdabre11 Every trade will include Wiggs and once you do that your best POA wing defender is gone"  
[X Link](https://x.com/tradingsssss/status/1854917963163615643)  2024-11-08T16:04Z [----] followers, [---] engagements


"@Himothy7777 @301lillian @trillsamsonite @joelvmoran Rodman is there for almost the same (better by a chip and a DPOY) reasons as dray tho i don't think its that out of the picture he's quite close to gary payton too with more chips"  
[X Link](https://x.com/tradingsssss/status/1856625372227621179)  2024-11-13T09:09Z [----] followers, [---] engagements


"@Notasalad @bballbreakdown it gave them a wide-open look and that pass was supposed to be for lindy water jr who is an elite shooter"  
[X Link](https://x.com/tradingsssss/status/1858755655768961062)  2024-11-19T06:14Z [----] followers, [---] engagements


"$ACHL looks decent here - in a range but if it gets above [----] then it looks like it could run Tech looks like a science project tbh"  
[X Link](https://x.com/tradingsssss/status/1874670307669369015)  2025-01-02T04:13Z [----] followers, [---] engagements


"@BurnerDff @automaticnba sure they flop a lot more than steph and get more calls than steph so how come they don't just call the "real ones" on them"  
[X Link](https://x.com/tradingsssss/status/1876111117711552606)  2025-01-06T03:38Z [----] followers, [---] engagements


"@sharkbiotech skyrizi and rinvoq were developed internally and through bp collabs tho"  
[X Link](https://x.com/tradingsssss/status/1886807917770498338)  2025-02-04T16:03Z [----] followers, [---] engagements


"$BABA $9988.HK this is a cleaner chart than the US one and you can see the break out clearly here you don't fade these types of moves they are often the start of something"  
[X Link](https://x.com/tradingsssss/status/1891386264680546488)  2025-02-17T07:16Z [----] followers, [---] engagements


"$BABA $9988.HK looks good here Retest of the trend was bought up aggressively by China"  
[X Link](https://x.com/tradingsssss/status/1894576571950010403)  2025-02-26T02:33Z [----] followers, [---] engagements


"@ImTheBestNerd @samesfandiari he doesnt need to be the number one option so he can spend some energy on this side of the floor"  
[X Link](https://x.com/tradingsssss/status/1899316328240185356)  2025-03-11T04:27Z [----] followers, [----] engagements


"@Supah_Mari0 ant's ankle will be swollen for game [--] too"  
[X Link](https://x.com/tradingsssss/status/1920678303590965486)  2025-05-09T03:12Z [----] followers, [----] engagements


"@ddpage369 @plusEVRaisin Sure but hes only missed [--] playoff games in his last [---] playoff games crazy to say that that is injury prone"  
[X Link](https://x.com/tradingsssss/status/1921213374429372619)  2025-05-10T14:38Z [----] followers, [---] engagements


"@MKFTST @Neymar10730 @playoffjake [----] would not be close if Iggy played the last [--] games whether CP3 was healthy or not"  
[X Link](https://x.com/tradingsssss/status/1921488342970970230)  2025-05-11T08:51Z [----] followers, [----] engagements


"@TheManJayJayyy @whotfamiiiiiii @NandoNando234 its a lot harder said than done tho a lot of the things that has made this team great is the versatility from 1-9. Youll lose 7-9 pretty easily as theyll get paid Finding those gems but yes having picks makes it easy"  
[X Link](https://x.com/tradingsssss/status/1928280819790954640)  2025-05-30T02:42Z [----] followers, [---] engagements


"@wchpwo @BonesAlecks @AndrewDBailey Rockets would foul out by half time if they played OKC"  
[X Link](https://x.com/tradingsssss/status/1929106944955953497)  2025-06-01T09:25Z [----] followers, [---] engagements


"$srpt final thoughts bad news like these are good markers on where we are on this rebound. If bad news gets absorbed then thats very bullish. If it goes down bad then thats probably a good time to be cautious for now"  
[X Link](https://x.com/tradingsssss/status/1954362533235884461)  2025-08-10T02:01Z [----] followers, [----] engagements


"$SRPT nobody say anything plssss"  
[X Link](https://x.com/tradingsssss/status/1954905564636762130)  2025-08-11T13:59Z [----] followers, [---] engagements


"$NKTR pls one shot it to [---] - lilly settlement - RezPeg AD crossover data $NKTR bye bye OX-40 cant believe they give us the opp to buy in the 20s https://t.co/xs00xY8jAL $NKTR bye bye OX-40 cant believe they give us the opp to buy in the 20s https://t.co/xs00xY8jAL"  
[X Link](https://x.com/tradingsssss/status/1968150436642451864)  2025-09-17T03:10Z [----] followers, [----] engagements


"think we finally have a bio podcast @A_May_MD @seedy19tron that's my biosquidgames pick for next [--] years"  
[X Link](https://x.com/tradingsssss/status/1975359938475270225)  2025-10-07T00:38Z [----] followers, [----] engagements


"Seeing a lot of people take profit on $NKTR If its your personal situation& strategy I get it But if youre selling just bc its gone up a lot then I think you may regret that Trends up valuation is still half of peak sales (conservative) potential settlement talks $NKTR this was a crazy turn around from range lows cant wait for it to just grind higher from here https://t.co/6L3aXVxTIa $NKTR this was a crazy turn around from range lows cant wait for it to just grind higher from here https://t.co/6L3aXVxTIa"  
[X Link](https://x.com/tradingsssss/status/1980480076451049664)  2025-10-21T03:43Z [----] followers, [----] engagements


"I know $NKTR is starting to be a cult stock bc I got [--] likes on this 😂😂😂 Seeing a lot of people take profit on $NKTR If its your personal situation& strategy I get it But if youre selling just bc its gone up a lot then I think you may regret that Trends up valuation is still half of peak sales (conservative) potential settlement talks Seeing a lot of people take profit on $NKTR If its your personal situation& strategy I get it But if youre selling just bc its gone up a lot then I think you may regret that Trends up valuation is still half of peak sales (conservative) potential settlement"  
[X Link](https://x.com/tradingsssss/status/1980607859563065473)  2025-10-21T12:11Z [----] followers, [----] engagements


"@automaticnba @big_business_ Health is probably the only thing stopping his generational run"  
[X Link](https://x.com/tradingsssss/status/1981218319840792623)  2025-10-23T04:37Z [----] followers, [---] engagements


"Timing of this is uncanny Expect another Grade [--] liver elevation from $NTLA As long as it is transient no Hys Law and clears by itself it is a non-issue imo. However we know how the market likes to punish Intellia for sneezing so it would be foolish to not expect red on that news. Expect another Grade [--] liver elevation from $NTLA As long as it is transient no Hys Law and clears by itself it is a non-issue imo. However we know how the market likes to punish Intellia for sneezing so it would be foolish to not expect red on that news"  
[X Link](https://x.com/tradingsssss/status/1982775793580412945)  2025-10-27T11:46Z [----] followers, [----] engagements


"$ARQT Close last month was the key but I didnt take and fumbled Congrats to the longs"  
[X Link](https://x.com/tradingsssss/status/1983177771447951676)  2025-10-28T14:23Z [----] followers, [----] engagements


"$ABVX just keeps closing above previous highs"  
[X Link](https://x.com/tradingsssss/status/1984628890887995899)  2025-11-01T14:29Z [----] followers, [----] engagements


"$NKTR great weekly close and daily too just wished it didn't wick some of the previous highs"  
[X Link](https://x.com/tradingsssss/status/1984629200981225622)  2025-11-01T14:30Z [----] followers, [----] engagements


"$CCCC above this area again"  
[X Link](https://x.com/tradingsssss/status/1996395669905654134)  2025-12-04T01:46Z [----] followers, [---] engagements


"$ORKA interesting here"  
[X Link](https://x.com/tradingsssss/status/2014865752277610911)  2026-01-24T01:00Z [----] followers, [---] engagements


"$ORKA looks good here"  
[X Link](https://x.com/tradingsssss/status/2015799266707726397)  2026-01-26T14:49Z [----] followers, [---] engagements


"$ORKA trading view is not so good with these types of scenarios - id have to program the EMAs to only take into account a certain date but i think id have to program an EMA indicator from scratch to do that on their system regardless daily EMAs are probably better to use and it looks good https://twitter.com/i/web/status/2016326194481005033 https://twitter.com/i/web/status/2016326194481005033"  
[X Link](https://x.com/tradingsssss/status/2016326194481005033)  2026-01-28T01:43Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing